medigraphic.com
ISSN 0016-3813 (Print)

2019, Number 1

<< Back Next >>

Gac Med Mex 2019; 155 (1)

Prevalencia de complicaciones de la diabetes y comorbilidades asociadas en medicina familiar del Instituto Mexicano del Seguro Social

Ovalle-Luna OD, Jiménez-Martínez IA, Rascón-Pacheco RA, Gómez-Díaz RA, Valdez-González AL, Gamiochipi-Cano M, Doubova SV, Valladares-Salgado A, Mondragón-González R, Méndez-Padrón A, Sánchez-Becerra MC, Cruz M, Salinas-Martínez AM, Garza-Sagástegui MG, Hernández-Rubí J, González-Hermosillo A, Vargas-Sánchez HR, Reyes M, Borja-Aburto VH, Wacher NH

Language: Spanish
References: 36
Page: 30-38
PDF size: 348.85 Kb.


ABSTRACT

Introduction: The prevalence of chronic complications and comorbidities in patients with type 2 diabetes (T2D) has increased worldwide. Objective: To compare the prevalence of complications and chronic comorbidities in patients with T2D at 36 family medicine units of five chapters of the Mexican Institute of Social Security (IMSS). Method: Complications (hypoglycemia, diabetic foot, kidney disease, retinopathy, ischemic heart disease, cerebrovascular disease and heart failure) and comorbidities (liver disease, cancer and anemia) were identified according to codes of the International Classification of Diseases, 10th Revision. Comparisons were made by chapter, age, gender and evolution time. Results: Complications and comorbidities were more common in subjects aged ≥ 62 years. Out of 297 100 patients, 34.9 % had any complication; microvascular complications (32 %) prevailed in the industrial North, whereas macrovascular complications (12.3 %) did in the rural East, and comorbidities (5 %) in southern Mexico City. Complications predominated in men (any complication, 30.2 %). Heart failure and comorbidities were more common in women (5.6 % and 4.9 %, respectively). Conclusions: T2D complications and comorbidities showed geographic and gender differences, and were greater with older age and longer evolution time. It is urgent for strategies for the prevention of complications and comorbidities to be reinforced in patients with T2D.


REFERENCES

  1. Diabetes Atlas Committee. Sexta edición. Bélgica: International Diabetes Federation; 2013.

  2. Alegre-Díaz J, Herrington W, López-Cervantes M, Gnatiuc L, Ramírez R, Hill M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961-1971.

  3. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. México: Instituto Nacional de Salud Pública; 2012.

  4. Encuesta Nacional de Salud y Nutrición en Medio Camino. Informe Final de Resultados. México: Instituto Nacional de Salud Pública; 2016.

  5. Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60:224-232.

  6. Sabag-Ruiz E, Álvarez-Félix A, Celiz-Zepeda S, Gómez-Alcalá AV. Complicaciones crónicas en la diabetes mellitus. Prevalencia en una unidad de medicina familiar. Rev Med Inst Mex Seguro Soc. 2006;44:415-421.

  7. Ibarra CT, Rocha JJ, Hernández R, Nieves RE, Leyva R. Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención. Rev Med Chile. 2012;140:1126-1131.

  8. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population ≥ 40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27:1591-1597.

  9. Alonso-Morán E, Orueta JF, Fraile-Esteban JI, Arteagoitia-Axpe JM, Marqués- González ML, Toro-Polanco N, et al. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health. 2014;14:1059.

  10. Giorda CB, Avogaro A, Maggini M, Lombardo F, Mannucci E, Turco S, et al. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke. 2007;38:1154-1160.

  11. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, KORA Study Group. Prevalence of polyneuropathy in prediabetes and diabetes is associated with abdominal obesity and macroangiopathy. Diabetes Care. 2008;31:464-469.

  12. Wong TY, Mwamburi M, Klein R, Larsen M, Flynn H, Hernández-Medina M, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic and meta-analysis. Diabetes Care. 2009;32:2307-2313.

  13. Wong TY, Klein R, Amirul-Islam A, Cotch MF, Couper DJ, Klein BE, et al. Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study. Am J Opthalmol. 2007;143:970-976.

  14. Morgan C, Peters J, Currie C. The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK. Diabet Med. 2010;27:673-678.

  15. Lugo-Palacios DG, Cairns J, Masetto C. Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security ( MSS). BMC Health Serv Res. 2016;16:333.

  16. Ascencio-Montiel IJ, Kumate-Rodríguez J, Borja-Aburto VH, Fernández- Garate JE, Konik-Comonfort S, Macías-Pérez O, et al. Survival rates and worker compensation expenses in a national cohort of Mexican workers with permanent occupational disability caused by diabetes. BMC Public Health. 2016;16:921.

  17. Arredondo A, Azar A, Recamán AL. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America. Glob Public Health. 2018;13:780-787.

  18. Mayfield JA, Strand T, Toya A. A call for specific codes for diabetes foot and eye care. Diabetes Care. 1995;18(3):418-421.

  19. Cisneros-González N, Ascencio-Montiel IJ, Libreros-Bango VN, Rodríguez- Vázquez H, Campos-Hernández A, Dávila-Torres J, et al. Índice de amputaciones de extremidades inferiores en pacientes con diabetes. Rev Med Inst Mex Seguro Soc. 2016; 54:472-479.

  20. Morbach S, Lutale JK, Viswanathan V, Möllenberg J, Ochs HR, Rajashekar S, et al. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med. 2004; 21:91-95.

  21. Hill CJ, Cardwell C, Patterson C, Maxwell AP, Magee GM, Young RJ, et al. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit. Diabet Med. 2014;31:448-454.

  22. Asociación Mexicana de Retina, Sociedad Mexicana de Oftalmología, Asociación Panamericana de Oftalmología. Resultados del Día Panamericano de Detección de Retinopatía Diabética (3 de julio de 1999, día “D”). Rev Mex Oftalmol. 2005;79:88-92.

  23. Yau J, Rogers S, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35 556-564.

  24. Wacher N, Silva M, Valdez L, Cruz M, Gómez-Diaz R. Causas de descontrol metabólico en atención primaria. Gac Med Mex. 2016;152:350-356.

  25. Bragg F, Li L, Smith M, Guo Y, Chen Y, Millwood I, et al.; China Kadoorie Biobank Collaborative Group. Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank. Diabet Med. 2014;31:540-551.

  26. Yeap B, McCaul K, Flicker L, Hankey GJ, Almeida OP, Golledge J, et al. Diabetes, myocardial infarction and stroke are distinct and duration- dependent predictors of subsequent cardiovascular events and all-cause mortality in older men. J Clin Endocrinol Metab. 2015; 100:1038-1047.

  27. Borja-Aburto V, González-Anaya J, Dávila-Torres J, Rascón-Pacheco RA, González-León M. Evaluation of the impact on non-communicable chronic diseases of a major integrated primary health care program in Mexico. Fam Pract. 2015;33:219-225.

  28. Cristina T, Williams J, Parkinson L, Sibbritt DW, Byles JE. Identification of diabetes, heart disease, hypertension and stroke in mid- and older- aged women: comparing self-report and administrative hospital data records. Geriatr Gerontol Int. 2016;16 95-102.

  29. Low Wang C, Hess CN, Hiatt W, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus. Mechanisms, management, and clinical considerations. Circulation. 2016;133:2459-2502.

  30. Joost H. Diabetes and cancer: epidemiology and potential mechanisms. Diab Vasc Dis Res. 2014;11:390-394.

  31. Jones S, Smith D, Nag S, Bilous MT, Winship S, Wood A, et al. Prevalence and nature of anaemia in a prospective, population-based sample of people with diabetes: Teesside anaemia in diabetes (TAD) study. Diabet Med. 2010;27:655-659.

  32. Elkrief L, Rautou PE, Sarin S, Valla D, Paradis V, Moreau R. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int. 2016;36:936-948.

  33. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10(6):330-344.

  34. Khunti K, Alsifri S, Aronson R, Cigrovski-Berković M, Enters-Weijnen C, Forsén T, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016;18 907-915.

  35. Flores-Hernández S, Saturno-Hernández P, Reyes-Morales H, Barrientos- Gutiérrez T, Villalpando S, Hernández-Ávila M. Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PLoS One. 2015;10: e0133958.

  36. Wacher NH, Reyes-Sánchez M, Vargas-Sánchez HR, Gamiochipi-Cano M, Rascón-Pacheco RA, Gómez-Díaz RA, et al. Stepwise strategies to successfully recruit diabetes patients in a large research study in Mexican population. Prim Care Diabetes. 2017;11 297-304.




2020     |     www.medigraphic.com